[(18)F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients

SIMPLE SUMMARY: In the challenge between increasingly sensitive PET radiopharmaceuticals for the evaluation of prostate cancer patient in biochemical relapse, the choice of the most accurate PET tracer must be guided by literature data, but above all tailored to the patient’s profile. In describing...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappi, Anna Giulia, Ferrari, Cristina, Mammucci, Paolo, Rubini, Dino, Lavelli, Valentina, Sardaro, Angela, Pisani, Antonio Rosario, Rubini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946770/
https://www.ncbi.nlm.nih.gov/pubmed/35326614
http://dx.doi.org/10.3390/cancers14061461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946770/
https://www.ncbi.nlm.nih.gov/pubmed/35326614
http://dx.doi.org/10.3390/cancers14061461

Ejemplares similares